Maurice Zauderer Ph.D.
Net Worth

Last updated:

What is Maurice Zauderer Ph.D. net worth?

The estimated net worth of Dr. Maurice Zauderer Ph.D. is at least $2,156,854 as of 4 Oct 2023. He owns shares worth $13,294 as insider and has received compensation worth at least $2,143,560 in Vaccinex, Inc..

What is the salary of Maurice Zauderer Ph.D.?

Dr. Maurice Zauderer Ph.D. salary is $357,260 per year as Co-Founder, Chief Executive Officer, Pres & Director in Vaccinex, Inc..

How old is Maurice Zauderer Ph.D.?

Dr. Maurice Zauderer Ph.D. is 79 years old, born in 1946.

What stocks does Maurice Zauderer Ph.D. currently own?

As insider, Dr. Maurice Zauderer Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Vaccinex, Inc. (VCNX) Co-Founder, Chief Executive Officer, Pres & Director 22,116 $0.6 $13,294

What does Vaccinex, Inc. do?

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that completed and planned Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

Maurice Zauderer Ph.D. insider trading

Vaccinex, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $0.97 $4,865
Purchase
Warrant (Right to Buy) 500,000 $1 $500,000
Purchase
Common Stock 5,000 $0.93 $4,650
Purchase
Common Stock 500,000 $1 $500,000
Purchase
Common Stock 1,801,801 $1.11 $1,999,999
Purchase
Common Stock 98,231 $5.09 $499,996
Purchase
Common Stock 183,824 $4.08 $750,002

Vaccinex key executives

Vaccinex, Inc. executives and other stock owners filed with the SEC: